Overview

Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML

Status:
RECRUITING

Trial end date:
2027-06-30

Target enrollment:

Participant gender:

Summary

A multicenter, prospective, single-arm clinical study of veneclax, chidaniline combined with azacitidine (VCA) followed by decitabine + MAG regimen (D-MAG) in the treatment of elderly untreated acute myeloid leukemia (AML)

Phase:

PHASE2

Details

Lead Sponsor:

The First Affiliated Hospital of Xiamen University

Collaborators:

Fujian Cancer Hospital
Fujian Provincial Hospital
Huizhou Municipal Central Hospital
Jieyang People's Hospital
Zhangzhou Affiliated Hospital of Fujian Medical University

Treatments:

Azacitidine